Advanced search

Filters

Capitalization

Sector

Select all

Add a keyword

Announcement Date

Since

Until

25 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : ADC Therapeutics SA - Special Call	Apr. 09
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024	Apr. 03	GL
Transcript : ADC Therapeutics SA, Q4 2023 Earnings Call, Mar 13, 2024	Mar. 13
Foresight Diagnostics Presents Four Presentations and Two Posters demonstrating accuracy and utility of PhasED-Seq ctDNA platform for early response assessment at the 65th American Society of Hematology	Dec. 13	AQ
ADC Therapeutics : Annual Report - Form 6-K	23-03-15	PU
Biocytogen Enters into Antibody Agreement with ADC Therapeutics	22-11-28	BU
Transcript : ADC Therapeutics SA - Special Call	22-02-08
ADC Therapeutics Highlights its Proprietary ADC Platform and Solid Tumor Pipeline	22-02-08	BU
ADC Therapeutics : to Host Webcast Highlighting its ADC Platform and Solid Tumor Pipeline on February 8, 2022 - Form 6-K	22-01-20	PU
ADC Therapeutics to Host Webcast Highlighting its ADC Platform and Solid Tumor Pipeline on February 8, 2022	22-01-20	BU
ADC Therapeutics : Announces Publication Highlighting the Potential of Camidanlumab Tesirine (Cami) as a Novel Immuno-oncology Approach for Solid Tumor Cancers	20-09-10	BU
ADC Therapeutics : and Freenome Enter Biomarker Development Collaboration	19-08-26	EQ
ADC Therapeutics and Freenome Enter Biomarker Development Collaboration	19-08-26	GL
ADC Therapeutics : and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial	19-08-06	EQ
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial	19-08-06	GL
ADC Therapeutics : and Adagene Announce License Agreement	19-04-24	EQ
ADC Therapeutics and Adagene Announce License Agreement	19-04-24	GL
ADC Therapeutics : Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors	19-01-04	EQ
ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors	19-01-04	GL
ADC Therapeutics : Announces Presentations at the Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting	18-11-08	EQ
ADC Therapeutics Announces Presentations at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting	18-11-08	GL
BREAKING: U.S. House candidate Pete Stauber used government email for political correspondence \| Star Tribune	18-09-06	PU
48 Women Entrepreneurs to Attend FWE's Sold Out Inaugural Educational + Mentorship Program in Toronto	16-10-24	MW
ADC Therapeutics : Announces Positive Pre-clinical Results for Two of its Novel ADCs at the American Society of Hematology Conference	15-12-05	BU
ADC Therapeutics Appoints Patrick Van Berkel as Senior Vice President, Research & Development	12-07-17	CI

No results for this search